Literature DB >> 27118802

The environmental source of emerging Apophysomyces variabilis infection in India.

Hariprasath Prakash1, Anup Kumar Ghosh1, Shivaprakash Mandya Rudramurthy1, Raees Ahmad Paul1, Sunita Gupta1, Vishwanand Negi1, Arunaloke Chakrabarti2.   

Abstract

The rare mucoraceous fungus, Apophysomyces species complex ranks second after Rhizopus arrhizus causing mucormycosis in India. The source of this agent in the environment is not clearly known. We conducted an environmental study to find its presence in Indian soil. The soil samples from different geographical locations were analyzed for isolation of Mucorales. Rhizopus arrhizus (24.6%) was most commonly isolated from soil, followed by Lichtheimia spp. (23.2%), Cunninghamella spp. (21.7%), Rhizopus microsporus (14%) and Apophysomyces spp. (4.5%). The isolation of Apophysomyces species complex was significantly associated with low nitrogen content of the soil. Based on sequencing of internal transcribed spacer (ITS) and 28S (D1/D2) regions of ribosomal DNA, the Apophysomyces isolates were identified as Apophysomyces variabilis with 98 to 100% similarity to type strain A. variabilis (CBS658.93). The analysis of amplified fragment length polymorphism (AFLP) fingerprinting data demonstrated genomic diversity of A. variabilis isolates with multiple clades (similarity 40-90%). The minimum inhibitory concentrations (MIC), MIC50 and MIC90 for A. variabilis isolates were 1 and 4 μg/ml for amphotericin B, 0.25 and 0.5 μg/ml for itraconazole, 0.125 and 0.25 μg/ml for posaconazole, 0.06 and 0.12 μg/ml for terbinafine, respectively. The present study revealed abundant presence of A. variabilis in Indian soil with low nitrogen content, its genetic heterogeneity and relatively high MICs for amphotericin B.
© The Author 2016. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AFLP; Apophysomyces variabilis; Mucorales; amphotericin B; antifungal susceptibility testing; ecology; molecular typing

Mesh:

Substances:

Year:  2016        PMID: 27118802     DOI: 10.1093/mmy/myw014

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  16 in total

1.  Size and Zeta Potential Clicked Germination Attenuation and Anti-Sporangiospores Activity of PEI-Functionalized Silver Nanoparticles against COVID-19 Associated Mucorales (Rhizopus arrhizus).

Authors:  Atul Kumar Tiwari; Munesh Kumar Gupta; Govind Pandey; Ragini Tilak; Roger J Narayan; Prem C Pandey
Journal:  Nanomaterials (Basel)       Date:  2022-06-29       Impact factor: 5.719

2.  Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.

Authors:  Simple Bhadania; Neena Bhalodiya; Yashendra Sethi; Nirja Kaka; Swati Mishra; Neil Patel; Asad Ullah Wasim; Saumya S Joshi; Kenisha Shah
Journal:  Cureus       Date:  2021-12-21

3.  Apophysomyces variabilis: draft genome sequence and comparison of predictive virulence determinants with other medically important Mucorales.

Authors:  Hariprasath Prakash; Shivaprakash Mandya Rudramurthy; Prasad S Gandham; Anup Kumar Ghosh; Milner M Kumar; Chandan Badapanda; Arunaloke Chakrabarti
Journal:  BMC Genomics       Date:  2017-09-18       Impact factor: 3.969

4.  Drug-Resistant Epimutants Exhibit Organ-Specific Stability and Induction during Murine Infections Caused by the Human Fungal Pathogen Mucor circinelloides.

Authors:  Zanetta Chang; Joseph Heitman
Journal:  mBio       Date:  2019-11-05       Impact factor: 7.867

Review 5.  COVID-19 associated mucormycosis - An emerging threat.

Authors:  Chien-Ming Chao; Chih-Cheng Lai; Wen-Liang Yu
Journal:  J Microbiol Immunol Infect       Date:  2022-01-13       Impact factor: 10.273

6.  Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient.

Authors:  José Y Rodríguez; Soraya E Morales-López; Gerson J Rodríguez; Carlos A Álvarez-Moreno; Walter Ocampo; Martha L Cepeda; Miguel A Mora-Valderrama
Journal:  Med Mycol Case Rep       Date:  2017-12-21

Review 7.  Biotic Environments Supporting the Persistence of Clinically Relevant Mucormycetes.

Authors:  Malcolm D Richardson; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2019-12-20

8.  Necrotizing fasciitis caused by Apophysomyces variabilis in a burn patient.

Authors:  Arghadip Samaddar; Anuradha Sharma; Vinod Kumar Maurya; Vibhor Tak
Journal:  IDCases       Date:  2019-11-02

Review 9.  Epidemiology and Diagnosis of Mucormycosis: An Update.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  J Fungi (Basel)       Date:  2020-11-02

Review 10.  Epidemiology of Mucormycosis in India.

Authors:  Hariprasath Prakash; Arunaloke Chakrabarti
Journal:  Microorganisms       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.